Control of proliferation and survival of C6 glioma cells with modification of the nerve growth factor autocrine system

Journal of Neuro-Oncology

Volumn 41, Issue 2, 1999, Pages 121-128

  Watanabe, Takao ^a,b   Katayama, Yoichi ^a   Kimura, Sigeyoshi ^a   Yoshino, Atsuo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Neurological Surgery ^*  (Japan)

Author keywords

Apoptosis; C6 glioma; Cell death; Nerve growth factor

Indexed keywords

CYCLOHEXIMIDE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIC FACTOR; PROTEIN;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL COUNT; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DNA SYNTHESIS; GLIA CELL; GLIOMA CELL; NERVE CELL DIFFERENTIATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT;

ANIMALS; AUTOCRINE COMMUNICATION; CELL COUNT; CELL DIVISION; CELL SURVIVAL; CYCLOHEXIMIDE; GLIOMA; NERVE GROWTH FACTORS; PROTEIN SYNTHESIS INHIBITORS; RATS; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0032961048     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006127624487     Document Type: Article

References (29)

1. Greene LA, Tischler AS: Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to NGF. Proc Natl Acad Sci USA 73: 2424-2428, 1976
2. Greene LA, Shooter EM: The nerve growth factor: Biochemistry, synthesis, and mechanism of action. Ann Rev Neurosci 3: 353-402, 1980
3. Kaplan DR, Martin-Zanca, Parada LF: Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 350: 158-160, 1991
4. Kaplan DR, Hempstead BL, Martin-Zanca, Chao MV: The trk proto-oncogene product: A signal transducing receptor for nerve growth factor. Science 252: 554-558, 1991
5. Johnson EM Jr, Gorin PD, Brandeis LD, Pearson J: Dorsal root ganglion neurons are destroyed by exposure in utero to maternal antibody to nerve growth factor. Science 210: 916-918, 1980
6. Levi-Montalcini R, Booker B: Destruction of sympathetic ganglia in mammals by an antiserum to the nerve-growth promoting factor. Proc Natl Acad Sci USA 42: 384-391, 1960
7. Martin DP, Schmidt RE, Distefano PS, Lowry OH, Capter JG, Johonson EM Jr: Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 106: 829-844, 1988
8. Marushige Y, Marushige K, Okazaki DL, Koestner A: Cytoskeletal reorganization induced by nerve growth factor and glial maturation factor in anaplastic glioma cells. Anticancer Res 9: 1143-1148, 1989
9. Yankner BA, Shooter EM: The biology and mechanism of action of nerve growth factor. Ann Rev Biochem 51: 845-868, 1984
10. Bernd P: Characterization of nerve growth factor binding to cultured neural crest cells: Evidence of an early developmental form of the NGF receptor. Dev Biol 115: 415-424, 1986
11. Greiner CAM, Lloyd AT, Guroff G: Ontogeny of the nerve growth factor receptor in primary cultures of neural crest cells. Dev Brain Res 26: 145-150, 1986
12. Kumar S, Huber J, Pena LA, Perez-Polo JR, Werrbach-Perez K, de Vellis J: Characterization of functional nerve growth factor-receptors in a CNS glial cell line: Monoclonal antibody 217c recognizes the nerve growth factor-receptor on C6 glioma cells. J Neurosci Res 27: 408-417, 1990
13. Muller HW, Beckh S, Seifert W: Neurotrophic factor for central neurons. Proc Natl Acad Sci USA 86: 1248-1252, 1984
14. Westermann R, Hardung M, Meyer DK, Ehrhard P, Otten U, Unsicker K: Neurotrophic factors released by C6 glioma cells. J Neurochem 50: 1747-1758, 1988
15. Zurn AD, Nick H, Monard D: A glia-derived nexin promotes neurite outgrowth in cultured chick sympathetic neurons. Dev Neurosci 10: 17-24, 1988
16. Lowe WL Jr, MeyerT, Karpen CW, Lorentzen LR: Regulation of insulin-like growth factor I production in rat C6 glioma cells: Possible role as an autocrine/paracrine growth factor. Endocrinology 130: 2683-2691, 1992
17. Hsu SN, Raine L, Fanger H: The use of avidinbiotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577, 1981
18. Ross AH, Grob P, Bothwell M, Elder DE, Ernst CS, Marano N, Ghrist BFD, Slemp CC, HerlynM , Atkinson B, Koprowski H: Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. Proc Natl Acad Sci USA 81: 6681-6685, 19
19. Marushige Y, Raiju NR, Marushige K, Koestner A: Modulation of growth and of morphological characteristics in glioma cells by nerve growth factor and glial maturation factor. Cancer Res 47: 4109-4115, 1987
20. Thoenen H: The changing scene of neurotrophic factors. Trends Neurosci 14: 165-170, 1991
21. Boonstra J, Mummery CL, Feyen A, de Hoog WJ, van der Saag PT, de laat SW: Epidermal growth factor receptor expression during morphological differentiation of pheochromocytoma cells, induced by nerve growth factor or dibutyryl cyclic AMP. J Cell Physiol 131: 409-417, 1987
22. Koike T: Molecular and cellular mechanism of neuronal degeneration caused by nerve growth factor deprivation approached through PC12 cell culture. Prog Neuro-Psychopharmacol Biol-Psychiat 16: 107-115, 1992
23. Jensen LM, Zhang Y, Shooter EM: Steady-state polypeptide modulations associated with nerve growth factor (NGF)-induced terminal differentiation and NGF deprivation-induced apoptosis in human neuroblastoma cells. J Biol Chem 267: 19325-19333, 1992
24. Li XN, Du ZW, Huang Q: Modulation effect of hexamethylene bisacetamide on growth and differentiation of cultured human malignant glioma cells. J Neurosurg 84: 831-838, 1996.
25. Li XN, Du ZW, Huang Q, Wu JQ: Growth-inhibitory and differentiation-inducing activity of dimethylformamide in cultured human malignant glioma cells. Neurosurgery 40: 1250-1259, 1997
26. Linskey ME, Gilbert MR: Glial differentiation: A review with implications for new directions in neuro-oncology. Neurosurgery 36: 1-22, 1995
27. Rutka JT, Smith SL: Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: Analysis of expression, proliferation, and tumorigenicity. Cancer Res 53: 3624-3631, 1993
28. Rutka JT, Hubbard SL, Fukuyama K, Matsuzawa K, Dirks PB, Becker LE: Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion and adhesion of human astrocytoma cells. Cancer Res 54: 3267-3272, 1994
29. Tanaka S, Nagashima T, Manaka S, Hori T, Yasumoto S: Growth suppression and astrocytic differentiation of glial cells by interleukin-1. J Neurosurg 81: 402-410, 1994